For example, administration of DOR agonists or enkephalinase inhibitors (the latter leading to increases in endogenous opioids) reduces depressive-like and anxiety-like behavior [16], [17], [53], [54], while systemic or cingulate cortex injection of DOR antagonists heightens anxiety [16], [55], [56]. This evidence concerns the gene MME and Anxiety.